AJOVista’s LeMaitre Vascular LMAT Stock Holding History

AJOVista’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-334	Closed	-$19K	–	250
2023 Q4	$19K	Buy	+334	New	+$17.5K	0.02%	365

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJOVista's LMAT Position: Q1 2024 in Review

AJOVista sold out of LeMaitre Vascular (LMAT) in Q1 2024, closing a stake of 334 shares — an estimated $19K sold.

AJOVista first reported a position in LMAT in Q4 2023 and held it in 1 quarter. The position peaked at $19K in Q4 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.

AJOVista reported no remaining LeMaitre Vascular position as of Q1 2024 after selling out during the quarter.
AJOVista sold 334 LeMaitre Vascular shares in Q1 2024, an estimated $19K.
AJOVista first reported a position in LeMaitre Vascular in Q4 2023 and held it in 1 quarter.
AJOVista's LeMaitre Vascular position peaked at $19K in Q4 2023.
243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.